ADI announces launch of AD-RIDDLE project

Alzheimer’s Disease International (ADI) has announced its participation in and launch of the AD-RIDDLE project.  

The project is a collaboration between academics, healthcare providers, pharmaceutical and diagnostic companies, regulatory bodies and patient advocacy organisations. It aims to improve detection, diagnosis and prevention of Alzheimer’s disease and, whilst initially focused on European countries, it’s hoped it will be translated worldwide in the future. 

The project aims to produce resources including: 

  • A digital community engagement portal. 
  • Screening tools for risk detection and early diagnosis.
  • A decision support toolkit for healthcare providers. 
  • Personalised therapies. 

You can find out more here: